Spectrum Pharmaceuticals COO Thomas Riga's 2018 pay jumps 388% to $5.3M
Spectrum Pharmaceuticals reports 2018 executive compensation
By ExecPay News
Published: April 23, 2019
Spectrum Pharmaceuticals reported fiscal year 2018 executive compensation information on April 23, 2019.
In 2018, four executives at Spectrum Pharmaceuticals received on average a compensation package of $4.4M, a 25% increase compared to previous year.
Average pay of disclosed executives at Spectrum Pharmaceuticals
Thomas J. Riga, Chief Operating Officer, received $5.3M in total, which increased by 388% compared to 2017. 55% of Riga's compensation, or $2.9M, was in stock awards. Riga also received $250K in bonus, $1.5M in option awards, $500K in salary, as well as $132K in other compensation.
For fiscal year 2018, the median employee pay was $158,730 at Spectrum Pharmaceuticals. Therefore, the ratio of Thomas J. Riga's pay to the median employee pay was 33 to one.
Keith M. McGahan, Chief Legal Officer, received a compensation package of $5.1M. 54% of the compensation package, or $2.8M, was in stock awards.
Joseph W. Turgeon, Chief Executive Officer, earned $4.7M in 2018, a 101% increase compared to previous year.
Kurt A. Gustafson, Chief Financial Officer, received $2.6M in 2018, which increases by 39% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 23, 2019.